# Diverse Scaffolds Facilitate NLRP3 Clustering and Inflammasome Formation in Response to Perturbations in Cell Homeostasis

**Authors:** Elvira Boršić‐Mlinarič, Iva Hafner‐Bratkovič

PMC · DOI: 10.1002/bies.70130 · 2026-03-25

## TL;DR

The NLRP3 inflammasome responds to various cellular disturbances by forming molecular scaffolds that help activate the immune system.

## Contribution

The paper proposes that diverse molecular scaffolds facilitate NLRP3 clustering and inflammasome formation in response to cellular perturbations.

## Key findings

- NLRP3 responds to changes in lipid membranes, protein localization, and organelle function.
- Molecular scaffolds recruit NLRP3 and promote its clustering and inflammasome assembly.
- NLRP3 acts as an adaptable sensor integrating multiple danger signals.

## Abstract

A central component of innate immunity, the NLRP3 inflammasome is a multiprotein complex formed in response to a chemically and morphologically diverse spectrum of stimuli. Despite extensive investigation, no single ligand or signal has emerged to account for this breadth of activation. Here, we review the landscape of NLRP3 activation across subcellular compartments and examine how this process is shaped by a network of interacting partners. Recent studies suggest that NLRP3 responds to cellular perturbations, such as changes in lipid membrane composition, protein localization, or organelle function. We propose that distinct upstream cues converge to generate diverse molecular scaffolds that recruit NLRP3. The NLRP3‐scaffold interactions promote NLRP3 clustering, destabilize its autoinhibited conformation, and drive assembly of the inflammasome. NLRP3 is thus an adaptable sensor, equipped with versatile molecular interactions that allow it to integrate multiple danger signals into inflammasome activation.

NLRP3, a cytosolic innate immune sensor, responds to diverse activators that perturb cellular homeostasis. These disturbances generate molecular scaffolds that, through binding partners such as nucleic acids, lipids, and proteins, recruit and concentrate NLRP3. Scaffold‐mediated NLRP3 clustering promotes NLRP3 inflammasome assembly.

## Linked entities

- **Genes:** NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548]

## Full-text entities

- **Genes:** GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, SCAP (SREBF chaperone) [NCBI Gene 22937], SREBF2 (sterol regulatory element binding transcription factor 2) [NCBI Gene 6721] {aka SREBP-2, SREBP2, bHLHd2}, CAPS (calcyphosine) [NCBI Gene 828] {aka CAPS1}, HDAC6 (histone deacetylase 6) [NCBI Gene 10013] {aka CPBHM, HD6, JM21, KDAC6, PPP1R90}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, NLRC4 (NLR family CARD domain containing 4) [NCBI Gene 58484] {aka AIFEC, CARD12, CLAN, CLAN1, CLANA, CLANB}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, DDX3X (DEAD-box helicase 3 X-linked) [NCBI Gene 1654] {aka CAP-Rf, DBX, DDX14, DDX3, HLP2, MRX102}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], Tardbp (TAR DNA binding protein) [NCBI Gene 230908] {aka 1190002A23Rik, TDP-43, Tdp43}, GBP5 (guanylate binding protein 5) [NCBI Gene 115362] {aka GBP-5}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, RAF1 (Raf-1 proto-oncogene, serine/threonine kinase) [NCBI Gene 5894] {aka CMD1NN, CRAF, NS5, Raf-1, c-Raf}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, ZC3HAV1 (zinc finger CCCH-type containing, antiviral 1) [NCBI Gene 56829] {aka ARTD13, FLB6421, PARP13, ZAP, ZC3H2, ZC3HDC2}, DHX33 (DEAH-box helicase 33) [NCBI Gene 56919] {aka DDX33}, TLR9 (toll like receptor 9) [NCBI Gene 54106] {aka CD289}, PRKD1 (protein kinase D1) [NCBI Gene 5587] {aka CHDED, PKC-MU, PKCM, PKD, PKD1, PRKCM}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, P2RX7 (purinergic receptor P2X 7) [NCBI Gene 5027] {aka P2X7}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, NEK7 (NIMA related kinase 7) [NCBI Gene 140609], Mark4 (MAP/microtubule affinity regulating kinase 4) [NCBI Gene 232944] {aka 2410090P21Rik, Markl1}, PYCARD (PYD and CARD domain containing) [NCBI Gene 29108] {aka ASC, CARD5, TMS, TMS-1, TMS1}, MAVS (mitochondrial antiviral signaling protein) [NCBI Gene 57506] {aka CARDIF, IPS-1, IPS1, VISA}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, RAB11A (RAB11A, member RAS oncogene family) [NCBI Gene 8766] {aka YL8}, NLRP11 (NLR family pyrin domain containing 11) [NCBI Gene 204801] {aka CLR19.6, NALP11, NOD17, PAN10, PYPAF6, PYPAF7}, OPTN (optineurin) [NCBI Gene 10133] {aka ALS12, FIP2, GLC1E, HIP7, HYPL, NRP}, MFN2 (mitofusin 2) [NCBI Gene 9927] {aka CMT2A, CMT2A2, CMT2A2A, CMT2A2B, CPRP1, HMSN6A}, NAIP (NLR family apoptosis inhibitory protein) [NCBI Gene 4671] {aka BIRC1, NLRB1, psiNAIP}, UCHL1 (ubiquitin C-terminal hydrolase L1) [NCBI Gene 7345] {aka HEL-117, HEL-S-53, NDGOA, PARK5, PGP 9.5, PGP9.5}, Pycard (PYD and CARD domain containing) [NCBI Gene 66824] {aka 9130417A21Rik, Asc, CARD5, TMS-1, TNS1, masc}, GOLGB1 (golgin B1) [NCBI Gene 2804] {aka GCP, GCP372, GOLIM1}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, CIITA (class II major histocompatibility complex transactivator) [NCBI Gene 4261] {aka C2TA, CIITAIV, MHC2D1, MHC2TA, NLRA}, AIM2 (absent in melanoma 2) [NCBI Gene 9447] {aka PYHIN4}, MARK4 (microtubule affinity regulating kinase 4) [NCBI Gene 57787] {aka MARK4L, MARK4S, MARKL1, MARKL1L, PAR-1D}, LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1) [NCBI Gene 55004] {aka C11orf59, PDRO, Ragulator1, p18, p27RF-Rho}, HK1 (hexokinase 1) [NCBI Gene 3098] {aka CNSHA5, HK, HK1-ta, HK1-tb, HK1-tc, HKD}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, Gbp5 (guanylate binding protein 5) [NCBI Gene 229898] {aka 5330409J06Rik, Gbp5a}, TNP1 (transition protein 1) [NCBI Gene 7141] {aka TP1}
- **Diseases:** metabolic disorders (MESH:D008659), viral infection (MESH:D014777), cerebral ischemia (MESH:D002545), cancer (MESH:D009369), inflammatory (MESH:D007249), infection (MESH:D007239), microbial infections (MESH:D015163), cryopyrin-associated periodic syndromes (MESH:D056587), brain injury (MESH:D001930), neuroinflammation (MESH:D000090862), GA (MESH:D007766), neurodegeneration (MESH:D019636), mitochondrial damage (MESH:D028361)
- **Chemicals:** phosphoinositides (MESH:D010716), Phospholipids (MESH:D010743), cardiolipin (MESH:D002308), LPS (MESH:D008070), ATP (MESH:D000255), nigericin (MESH:D009550), phosphatidic acid (MESH:D010712), cholesterol (MESH:D002784), ethidium bromide (MESH:D004996), PIP4 (-), PI(3,4,5)P3 (MESH:C118303), lipid (MESH:D008055), PI(3,5)P2 (MESH:C106336), PI4P (MESH:C037178), potassium (MESH:D011188)
- **Species:** Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Zika virus (no rank) [taxon 64320], Mus musculus (house mouse, species) [taxon 10090], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** L355P, L266F, V52G
- **Cell lines:** HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), 8EJ4 — Homo sapiens (Human), Endometrial adenocarcinoma, Cancer cell line (CVCL_7039), 7PZC — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_H340)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13015780/full.md

---
Source: https://tomesphere.com/paper/PMC13015780